Previous close | 18.42 |
Open | 18.43 |
Bid | 18.25 x 900 |
Ask | 18.75 x 2200 |
Day's range | 18.33 - 18.68 |
52-week range | 10.84 - 24.79 |
Volume | |
Avg. volume | 2,331,669 |
Market cap | 4.742B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 4.65 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.12 (6.04%) |
Ex-dividend date | 23 Feb 2024 |
1y target est | N/A |
JERSEY CITY, N.J., April 08, 2024--Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
SHANGHAI, China & JERSEY CITY, N.J., April 08, 2024--Organon and Henlius announce that Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoint
JERSEY CITY, N.J., February 20, 2024--Organon Announces HADLIMA Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary